EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sarcoidosis-Related Uveitis: A Review

Stéphane Giorgiutti iD, Robin Jacquot, Thomas El Jammal, Arthur Bert, Yvan Jamilloux iD, Laurent Kodjikian iD, Pascal Sève iD

Journal of Clinical Medicine · 29.04.2023 · 12 (9) · 3194

DOI: 10.3390/jcm12093194 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.04.2023. Verfasst von Stéphane Giorgiutti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Internal Medicine, National Center for Systemic Autoimmune Diseases (CNR RESO), Strasbourg University Hospital,…. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcoidosis is an inflammatory disease that involves the eyes in 10–55% of cases, sometimes without systemic involvement. All eye structures can be affected, but uveitis is the most common ocular manifestation and causes vision loss. The typical ophthalmological appearance of these uveitis is granulomatous (in cases with anterior involvement), which are usually bilateral and with synechiae. Posterior involvement includes vitritis, vasculitis and choroidal lesions. Tuberculosis is a classic differential diagnosis to be wary of, especially in people who have spent time in endemic areas. The diagnosis is based on histology with the presence of non-caseating epithelioid granulomas. However, due to the technical difficulty and yield of biopsies, the diagnosis of ocular sarcoidosis is often based on clinico-radiological features. The international criteria for the diagnosis of ocular sarcoidosis have recently been revised. Corticosteroids remain the first-line treatment for sarcoidosis, but up to 30% of patients require high doses, justifying the use of corticosteroid-sparing treatments. In these cases, immunosuppressive treatments such as methotrexate may be introduced. More recent biotherapies such as anti-TNF are also very effective (as they are in other non-infectious uveitis etiologies).

Schlagwörter

Stichwörter der Autor:innen

granulomaocular sarcoidosissarcoidosisuveitis

Autor:innen und Institutionen

  • Department of Clinical Immunology and Internal Medicine, National Center for Systemic Autoimmune Diseases (CNR RESO), Strasbourg University Hospital, 67000 Strasbourg, France.
  • INSERM UMR-S1109, Université de Strasbourg, 67000 Strasbourg, France.
  • Department of Internal Medicine, Croix-Rousse University Hospital, Hospices Civils de Lyon, 69004 Lyon, France.
  • Faculté de Médecine et de Maïeutique Lyon-Sud-Charles Mérieux, Université de Lyon, 69000 Lyon, France.
  • Laboratory of Tissue Biology and Therapeutic Engineering, CNRS UMR5305, IBCP, University of Lyon, 69007 Lyon, France.
  • Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, 69004 Lyon, France.

ORCID-Profile: Stéphane Giorgiutti, Yvan Jamilloux, Laurent Kodjikian, Pascal Sève

Zitieren

APA

Giorgiutti, S., Jacquot, R., El Jammal, T., Bert, A., Jamilloux, Y., Kodjikian, L., & Sève, P. (2023). Sarcoidosis-Related Uveitis: A Review. Journal of Clinical Medicine, 12(9), 3194. https://doi.org/10.3390/jcm12093194

Vancouver

Giorgiutti S, Jacquot R, El Jammal T, Bert A, Jamilloux Y, Kodjikian L, et al. Sarcoidosis-Related Uveitis: A Review. Journal of Clinical Medicine. 2023;12(9):3194. doi:10.3390/jcm12093194

BibTeX
@article{Giorgiutti2023,
  author = {Giorgiutti, Stéphane and Jacquot, Robin and El Jammal, Thomas and Bert, Arthur and Jamilloux, Yvan and Kodjikian, Laurent and Sève, Pascal},
  title = {Sarcoidosis-Related Uveitis: A Review},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {3194},
  doi = {10.3390/jcm12093194}
}
Kostenlos starten →